GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cdkn1a | multiple interactions | EXP | | 6480464 | CTD | [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein] | PMID:25478867 | Cdkn1a | increases expression | ISO | CDKN1A (Homo sapiens) | 6480464 | CTD | [Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A mRNA; [Butyric Acid results in increased expression of SRSF2 protein] which results in increased expression of CDKN1A protein; Butyric Acid results in increased expression of CDKN1A protein | PMID:15715472 PMID:21555914 | Cdkn1a | multiple interactions | ISO | CDKN1A (Homo sapiens) | 6480464 | CTD | [Butyric Acid co-treated with Quercetin] results in increased expression of CDKN1A protein | PMID:25070040 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |